Phase II clinical trial assessing the efficacy of enzalutamide in advanced non-resectable granulosa cell ovarian tumors: The GREKO III study (GETHI2016–01)

Update your browser to view ScienceDirect.

Request details:

Request ID: 8d849a1c3cd696b7-LAX
IP: 116.62.10.13
UTC time: 2024-10-25T19:27:05+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4